Trypanosoma cruzi: Plasma corticosterone after repetitive stress during the acute phase of infection

Experimental Parasitology

Volumn 117, Issue 4, 2007, Pages 405-410

  Santos, Carla D ^a   Prado Jr , José C ^a   Toldo, Míriam P A ^a   Levy, Antonio M A ^b   Franci, Celso R ^a   Caldeira, Jerri C ^c  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b INSTITUTO DANTE PAZZANESE DE CARDIOLOGIA   (Brazil)

^c FACULDADE DE MEDICINA DE SÃO JOSÉ DO RIO PRETO   (Brazil)

Author keywords

Corticosterone; Lytic antibody; Macrophages; Spleen; Stress; Trypanosoma cruzi

Indexed keywords

CORTICOSTERONE; PRASTERONE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; HISTOPATHOLOGY; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMUNE FUNCTION TEST; IMMUNOGLOBULIN PRODUCTION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SPLEEN WEIGHT; TREATMENT OUTCOME; TRYPANOSOMA CRUZI; TRYPANOSOMIASIS;

ANALYSIS OF VARIANCE; ANIMALS; CHAGAS DISEASE; CORTICOSTERONE; KARYOMETRY; MACROPHAGES, PERITONEAL; MALE; ORGAN SIZE; RATS; RATS, WISTAR; SPLEEN; STRESS;

ANIMALIA; RATTUS NORVEGICUS; TRYPANOSOMA CRUZI;

EID: 35748941271     PISSN: 00144894     EISSN: 10902449     Source Type: Journal    
DOI: 10.1016/j.exppara.2007.05.008     Document Type: Article

References (25)

1. Aliberti J.C., Cardoso M.A., Martins G.A., Gazzinelli R.T., Vieira L.Q., and Silva J.S. Interleukin-12 mediates resistance to Trypanosoma cruzi in mice and is produced by murine macrophages in response to live trypomastigotes. Infection and Immunity 64 (1996) 1961-1967
2. Bohus B., Koolhaas J.M., De Ruiter A.J.H., and Heijnen C.J. Stress and differential alterations in immune system functions: conclusions from social stress studies in animals. Netherlands Journal of Medicine 39 (1991) 306-315
3. Brener Z., and Krettli A.U. Immunology of Chagas′ disease. In: Wyler D.J. (Ed). Modern Parasite Biology-Cellular, Immunological and Molecular Aspects (1983), W.H. Freeman and Co., New York 47-261
4. Brener Z., and Gazzinelli R.T. Immunological control of Trypanosoma cruzi infection and pathogenesis of Chagas' disease. International Archives of Allergy and Immunology 114 (1997) 103-110
5. Caldeira J.C., and Franci C.R. Prolactin and Corticosterone secretion in response to acute stress after paraventricular nucleus lesion by ibotenic acid. Brain Research Bulletin 52 (2000) 483-489
6. Castro M.A.P., and Brener Z. Estudo parasitológico e anátomo-patológico da fase aguda da doença de Chagas em cães inoculados com duas diferentes cepas do Trypanosoma cruzi. Revista da Sociedade Brasileira de Medicina Tropical 18 (1985) 233-239
7. Chrousos G.P., and Gold P.W. The concepts of stress and stress system disorders. Overview of physical and behavioral homeostasis. Journal of the American Medical Association (JAMA) 267 (1992) 1244-1252
8. Connor T.J., Brewer C., Kelly J.P., and Harkin A. Acute stress suppresses pro-inflammatory cytokines TNF-alpha and IL-1 beta independent of a catecholamine-driven increase in IL-10 production. Journal of Neuroimmunology 159 (2005) 119-128
9. Dunn A.J., Wang J., and Ando T. Effects of cytokines on central neurotransmission: comparison with the effects of stress. Advances in Experimental Medicine and Biology 461 (1999) 117-127
10. Glaser R., Rice J., Speicher C.E., Stout J.C., and Kiecolt-Glaser J.K. Stress depresses interferon production by leukocytes concomitant with a decrease in natural killer cell activity. Behavior Neuroscience 100 (1986) 675-678
11. Khansari D.N., Murgo A.J., and Faith R.E. Effect stress on the immune system. Immunology Today 11 (1990) 170-175
12. Koolhaas J.M., De Boer S.F., De Ruiter A.J.H., Meerlo P., and Sgoifo A. Social stress in rats and mice. Acta Physiologyca Scandinavica 640 (1997) 69-72
13. Levy A.M.A., Boainain E., and Kloetzel J.K. In Situ Indirect Fluorescent Antibody: a new specific test to detect ongoing Chagasic infections. Journal of Clinical Laboratory Analysis 10 (1996) 98-103
14. McEween B.S. The neurobiology of stress: from serendipity to clinical relevance. Brain Research 886 (2000) 171-189
15. Sala M.A., Komesu M.C., Lopes R.A., and Maia Campos G. Karyometric study of basal cell carcinoma. Brazilian Dentist 5 (1994) 11-14
16. Santos C.D., Caldeira J.C., Toldo M.P., and Prado J.C. Trypanosoma cruzi: effects of repetitive stress during the development of experimental infection. Experimental Parasitology 110 (2005) 96-101
17. Santos C.D., Toldo M.P., and do Prado Junior J.C. Trypanosoma cruzi: the effects of dehydroepiandrosterone (DHEA) treatment during experimental infection. Acta Tropica 95 (2005) 109-115
18. Schuster J.P., and Schaub G.A. Experimental Chagas disease: the influence of sex and psychoneuroimmunological factors. Parasitology Research 87 (2001) 994-1000
19. Silva L.H.P., and Nussenszweig V. Sobre uma cepa de Trypanosoma cruzi altamente virulenta para o camundongo branco. Folia Clinica et Biologic 20 (1953) 191-208
20. Silva J.S., Morrissey P.J., Grabstein K.H., Mohler K.M., Anderson D., and Reed S.G. Interleukin-10 and interferon gamma regulation of experimental Trypanosoma cruzi infection. Journal of Experimental Medicine 175 (1992) 169-174
21. Silva J.S., Vespa G.N.R., Cardoso M.A.G., Aliberti J.C.S., and Cunha F.Q. Tumor necrosis factor alpha mediates resistance to Trypanosoma cruzi infection in mice by inducing nitric oxide production in infected gamma interferon-activated macrophages. Infection and Immunity 63 (1995) 4862-4867
22. Tseng R.J., Padgett D.A., Dhabhar F.S., Engler H., and Sheridan J.F. Stress-induced modulation of NK activity during influenza viral infection: role of glucocorticoids and opioids. Brain Behavior Immunity 19 (2005) 153-164
23. Touma C., Palme R., and Sachser N. Analyzing corticosterone metabolites in fecal samples of mice: a noninvasive technique to monitor stress hormones. Hormones and Behaviour 45 (2004) 10-22
24. Yan S.M., Finato N., Di Loreto C., and Beltrami C.A. Nuclear size of myocardial cells in end-stage cardiomyopathies. Analytical and Quantitative Cytology and Histology 21 (1999) 174-180
25. WHO Technical Report Series No. 811, 2002. Control of Chagas' disease, WHO, Geneve, p.23.